Mingjun Li
Impact in
-
- Lung Cancer Treatments and Mutations
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 4
-
- Bone Metabolism and Diseases 2
- Nicotinic Acetylcholine Receptors Study 1
- Co-authors
- Ningning Yan (2 shared papers)Xingya Li (2 shared papers)Wengang Wang (2 shared papers)Yongxu Jia (2 shared papers)Benling Xu (2 shared papers)Xiaofei Zhang (1 shared paper)Huijie Fan (2 shared papers)Yanru Qin (2 shared papers)
- Journals
- International Journal of Molecular Medicine (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)Tumor Biology (1 paper)JAMA (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- China
In The Last Decade
Mingjun Li
13 papers receiving 357 citations
Mingjun Li's Hit Papers
Peers
Comparison fields: 5 of 48
- Pulmonary and Respiratory Medicine 111
- Oncology 78
- Cancer Research 29
- Molecular Biology 99
- Biomaterials 19
Countries citing papers authored by Mingjun Li
This map shows the geographic impact of Mingjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Li more than expected).
Fields of papers citing papers by Mingjun Li
This network shows the impact of papers produced by Mingjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Li. The network helps show where Mingjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant Hit paper breakdown → | 2024 | 119 |
| 2 | 2022 | 55 | |
| 3 | 2015 | 31 | |
| 4 | 2017 | 30 | |
| 5 | 2020 | 27 | |
| 6 | 2021 | 24 | |
| 7 | 2017 | 18 | |
| 8 | 2022 | 18 | |
| 9 | 2014 | 17 | |
| 10 | 2025 | 8 | |
| 11 | 2012 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2024 | 2 | |
| 14 | 2026 | 0 |
About Mingjun Li
Mingjun Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Automotive Engineering and Insect Science, having authored 14 papers that have together received 363 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Bone Metabolism and Diseases (2 papers), Insect Pest Control Strategies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Insect and Pesticide Research (1 paper), Nicotinic Acetylcholine Receptors Study (1 paper) and Reinforcement Learning in Robotics (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (111 citations), Oncology (78 citations), Cancer Research (29 citations), Molecular Biology (99 citations) and Biomaterials (19 citations). Mingjun Li has collaborated with scholars based in China. Frequent co-authors include Ningning Yan, Xingya Li, Wengang Wang, Yongxu Jia, Benling Xu, Xiaofei Zhang, Huijie Fan, Yanru Qin, Xiaofei Zhang and Long Yuan. Their work appears in journals such as International Journal of Molecular Medicine, Colloids and Surfaces B Biointerfaces, Tumor Biology, JAMA and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.